CervoMed Inc. Cash and Restricted Cash
CervoMed Inc. (CRVO) had Cash and Restricted Cash of $10.50 million as of 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-05-12
- 2025-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.50M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.00M.
- 2024-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.74M.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.01M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2025-03-31 | $10.50M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $9.00M 10-Q · filed 2025-05-12 | |
| 2024-09-30 | $7.74M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $10.01M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $6.37M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $7.79M 10-Q · filed 2025-05-12 | |
| 2023-09-30 | $10.42M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $649.78K 10-Q · filed 2024-08-09 | $15.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.61M 10-Q · filed 2024-05-14 | $14.65M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $4.09M 10-K · filed 2025-03-17 | $10.11M 10-K · filed 2023-03-24 |
| 2022-09-30 | $4.79M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $5.97M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $9.87M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $6.67M 10-K · filed 2024-03-29 | $37.31M 10-K · filed 2022-03-18 |
| 2021-09-30 | $40.34M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $43.31M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $46.63M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $18.52M 10-K · filed 2023-03-24 | |
| 2020-09-30 | $21.91M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $25.56M 10-Q · filed 2021-08-11 | |
| 2020-03-31 | $10.83M 10-Q · filed 2021-05-07 | |
| 2019-12-31 | $14.18M 10-K · filed 2022-03-18 | |
| 2019-09-30 | $6.14M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $8.37M 10-Q · filed 2020-08-07 | |
| 2018-12-31 | $7.99M 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |